BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 36598092)

  • 1. Novel acetic acid derivatives containing quinazolin-4(3H)-one ring: Synthesis, in vitro, and in silico evaluation of potent aldose reductase inhibitors.
    Tokalı FS; Demir Y; Türkeş C; Dinçer B; Beydemir Ş
    Drug Dev Res; 2023 Apr; 84(2):275-295. PubMed ID: 36598092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, biological evaluation, and in silico study of novel library sulfonates containing quinazolin-4(3H)-one derivatives as potential aldose reductase inhibitors.
    Tokalı FS; Demir Y; Demircioğlu İH; Türkeş C; Kalay E; Şendil K; Beydemir Ş
    Drug Dev Res; 2022 May; 83(3):586-604. PubMed ID: 34585414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quinazolinone-based rhodanine-3-acetic acids as potent aldose reductase inhibitors: Synthesis, functional evaluation and molecular modeling study.
    El-Sayed S; Metwally K; El-Shanawani AA; Abdel-Aziz LM; El-Rashedy AA; Soliman MES; Quattrini L; Coviello V; la Motta C
    Bioorg Med Chem Lett; 2017 Oct; 27(20):4760-4764. PubMed ID: 28935265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, in vitro and in silico investigation of aldose reductase inhibitory effects of new thiazole-based compounds.
    Sever B; Altıntop MD; Demir Y; Akalın Çiftçi G; Beydemir Ş; Özdemir A
    Bioorg Chem; 2020 Sep; 102():104110. PubMed ID: 32739480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and characterization of novel acyl hydrazones derived from vanillin as potential aldose reductase inhibitors.
    Demir Y; Tokalı FS; Kalay E; Türkeş C; Tokalı P; Aslan ON; Şendil K; Beydemir Ş
    Mol Divers; 2023 Aug; 27(4):1713-1733. PubMed ID: 36103032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (4-Oxo-2-thioxothiazolidin-3-yl)acetic acids as potent and selective aldose reductase inhibitors.
    Kucerova-Chlupacova M; Halakova D; Majekova M; Treml J; Stefek M; Soltesova Prnova M
    Chem Biol Interact; 2020 Dec; 332():109286. PubMed ID: 33038328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and structure-activity relationship studies of quinoxaline derivatives as aldose reductase inhibitors.
    Wu B; Yang Y; Qin X; Zhang S; Jing C; Zhu C; Ma B
    ChemMedChem; 2013 Dec; 8(12):1913-7. PubMed ID: 24115741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new series of hydrazones as small-molecule aldose reductase inhibitors.
    Altıntop MD; Demir Y; Türkeş C; Öztürk RB; Cantürk Z; Beydemir Ş; Özdemir A
    Arch Pharm (Weinheim); 2023 Apr; 356(4):e2200570. PubMed ID: 36603162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological effects of bis-hydrazone compounds bearing isovanillin moiety on the aldose reductase.
    Yapar G; Esra Duran H; Lolak N; Akocak S; Türkeş C; Durgun M; Işık M; Beydemir Ş
    Bioorg Chem; 2021 Dec; 117():105473. PubMed ID: 34768205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel quinazolinone-based 2,4-thiazolidinedione-3-acetic acid derivatives as potent aldose reductase inhibitors.
    Metwally K; Pratsinis H; Kletsas D; Quattrini L; Coviello V; Motta C; El-Rashedy AA; Soliman ME
    Future Med Chem; 2017 Dec; 9(18):2147-2166. PubMed ID: 29098865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-substituted phthalazine sulfonamide derivatives as non-classical aldose reductase inhibitors.
    Türkeş C; Arslan M; Demir Y; Çoçaj L; Nixha AR; Beydemir Ş
    J Mol Recognit; 2022 Dec; 35(12):e2991. PubMed ID: 36073557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel synthesis of nitro-quinoxalinone derivatives as aldose reductase inhibitors.
    Hussain S; Parveen S; Qin X; Hao X; Zhang S; Chen X; Zhu C; Ma B
    Bioorg Med Chem Lett; 2014 May; 24(9):2086-9. PubMed ID: 24726808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and synthesis of novel quinazolin-4(1H)-one derivatives as potent and selective inhibitors targeting AKR1B1.
    Han Z; Li J; Xu Z; Su Y; Wang Y; Zhuo L; Du J; Zhu C; Hao X
    Arch Pharm (Weinheim); 2023 Apr; 356(4):e2200577. PubMed ID: 36707406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro studies of potent aldose reductase inhibitors: Synthesis, characterization, biological evaluation and docking analysis of rhodanine-3-hippuric acid derivatives.
    Celestina SK; Sundaram K; Ravi S
    Bioorg Chem; 2020 Apr; 97():103640. PubMed ID: 32086051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a new class of potent aldose reductase inhibitors: Design, microwave-assisted synthesis, in vitro and in silico evaluation of 2-pyrazolines.
    Sever B; Altıntop MD; Demir Y; Yılmaz N; Akalın Çiftçi G; Beydemir Ş; Özdemir A
    Chem Biol Interact; 2021 Aug; 345():109576. PubMed ID: 34252406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rhodanine-3-acetamide derivatives as aldose and aldehyde reductase inhibitors to treat diabetic complications: synthesis, biological evaluation, molecular docking and simulation studies.
    Bacha MM; Nadeem H; Zaib S; Sarwar S; Imran A; Rahman SU; Ali HS; Arif M; Iqbal J
    BMC Chem; 2021 Apr; 15(1):28. PubMed ID: 33906691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological evaluation of new epalrestat analogues as aldose reductase inhibitors (ARIs).
    Reddy TN; Ravinder M; Bagul P; Ravikanti K; Bagul C; Nanubolu JB; Srinivas K; Banerjee SK; Rao VJ
    Eur J Med Chem; 2014 Jan; 71():53-66. PubMed ID: 24275248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel spiroindoline derivatives targeting aldose reductase against diabetic complications: Bioactivity, cytotoxicity, and molecular modeling studies.
    Güleç Ö; Türkeş C; Arslan M; Demir Y; Dincer B; Ece A; İrfan Küfrevioğlu Ö; Beydemir Ş
    Bioorg Chem; 2024 Apr; 145():107221. PubMed ID: 38387398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (5-Hydroxy-4-oxo-2-styryl-4
    Chen H; Zhang X; Zhang X; Liu W; Lei Y; Zhu C; Ma B
    Molecules; 2020 Nov; 25(21):. PubMed ID: 33158254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, structure-activity relationships and X-ray structural studies of novel 1-oxopyrimido[4,5-c]quinoline-2-acetic acid derivatives as selective and potent inhibitors of human aldose reductase.
    Crespo I; Giménez-Dejoz J; Porté S; Cousido-Siah A; Mitschler A; Podjarny A; Pratsinis H; Kletsas D; Parés X; Ruiz FX; Metwally K; Farrés J
    Eur J Med Chem; 2018 May; 152():160-174. PubMed ID: 29705708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.